Photochemotherapy for Mycosis Fungoides
- 1 January 1979
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 115 (1) , 50-53
- https://doi.org/10.1001/archderm.1979.04010010022007
Abstract
Nine patients with stages 2 or 3 mycosis fungoides (MF) and one with Sézary's syndrome were treated with oral methoxsalen and long-wave ultraviolet light. Previous therapy had either failed or achieved only partial control. Satisfactory clinical control was achieved in all but one case. Histological improvement was seen in all cases, but complete clearance of lymphoid infiltrate was noted mainly in epidermal and papillary dermal infiltrates. Lower dermal infiltrate remained largely unchanged. The case of Sézary's syndrome was inadequately controlled with systemic prednisone and cyclophosphamide, but addition of photochemotherapy improved the erythema and pruritus. This shows that photochemotherapy may have a place in MF treatment both alone and perhaps in conjunction with other treatments. An early relapse occurred on stopping photochemotherapy in four cases, but one patient has had three months' full remission. (Arch Dermatol115:50-53, 1979)Keywords
This publication has 5 references indexed in Scilit:
- Spectrum of ultraviolet radiation on human B and T lymphocyte viabilityClinical and Experimental Dermatology, 1978
- Oral methoxsalen photochemotherapy of mycosis fungoidesCancer, 1976
- Treatment of mycosis fungoides with topical nitrosourea compounds: Further studiesArchives of Dermatology, 1975
- Prognostic signs and the management of the mycosis fungoidesCancer, 1973
- Photoinactivation of ehrlich ascites tumor cells in vitro obtained with skin-photosensitizing furocoumarinsCellular and Molecular Life Sciences, 1967